Keyword: commercialization rights
News
12.01.2017
- French drugmaker Ipsen has signed a definitive agreement to buy the global oncology assets of US-based Merrimack Pharmaceuticals in a deal worth potentially more than $1 billion...
News
03.01.2017
- Indian pharmaceutical company Zydus Cadila has acquired six brands from US drugmaker Merck for an undisclosed sum. The branded products are anabolic steroids Deca-Durabolin and...
